Catalent Pharma Solutions CEO Talks IPO, Potential Biotech Bubble - Presented by: The Aol. On Network

Catalent Pharma Solutions begins trading on the New York Stock Exchange Thursday under the ticker CTLT. Catalent's president and chief executive officer John Chiminski tells TheStreet's Brittany Umar why the company says it's the number one drug delivery technology company in the world and how it supports big pharmaceutical names like Johnson & Johnson and GlaxoSmithKline.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 17.62 0.09 ▲ 0.51%
GE $ 25.62 0.48 ▲ 1.91%
AAPL $ 111.78 0.87 ▼ 0.77%
INTC $ 36.37 0.65 ▼ 1.76%
MSFT $ 47.66 0.14 ▲ 0.29%
IAG $ 2.59 0.01 ▼ 0.38%
PBR/A $ 7.34 0.17 ▲ 2.37%
VALE $ 8.14 0.53 ▲ 6.96%

As of 12/19/2014, 04:15 PM
More Most Active

Latest News Headlines

View All